A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

(2010) Japan PPI (standard dose b.i.d.) Clarithromycin (200–400 mg b.i.d.) Amoxicillin (750 mg b.i.d.) 7 Metronidazole ... quadruple therapy, levofloxacin-based triple or quadruple therapy.

Urine samples taken by his GP identified Klebsiella pneumoniae and then man, from France, was given a five day course of the antibiotic levofloxacin. After five days, the patients was switched to ...

In an open-label, noncomparative study, gemifloxacin (320 mg, once daily for 7 days ... [73] In an economic evaluation of levofloxacin versus cefuroxime axetil in the treatment of outpatients ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...